Combined effect of letrozole and dydrogesterone versus dydrogesterone alone for relieving pain in patients with endometriosis
article
OA: diamond
CC0
Abstract
Background Endometriosis is a medical condition in women caused by the growth of active endometrial tissue outside the uterine cavity. It predominantly affects women of reproductive age and typically manifests as dysmenorrhea, dyspareunia, chronic pelvic pain, and infertility. It negatively impacts psychological well-being and health-related quality of life. Aim This study aims to compare the effect of the combination of letrozole and dydrogesterone versus the effect of dydrogesterone alone in pain-associated endometriosis Patients & Methods This randomized controlled study was conducted on 88 women with endometriosisassociated pain in the gynecologic outpatient clinic at Tanta University Hospitals, from October 2023 to September 2024. Patients were randomly divided into two equal groups, with 44 patients in each group. In the 1st group, Dydrogesterone (10 mg) twice daily and Letrozole (2.5 mg) once daily were administered from the 2nd day of menses continuously for 3 months. In the second group, Dydrogesterone (10 mg) was administered twice daily from the 2nd day of menses continuously for 3 months. The effectiveness of treatment was assessed by relief of symptoms. VAS, serum Estradiol, and CA 125 levels were measured before and after treatment. Results The mean age of patients was 30.11 ± 6.93 years in 1st group and 31.84 ± 7.98 years in 2nd group. Clinical effectiveness of treatment was significant in both groups but significantly better in the 1st group (40 patients, 90.90%) than the 2nd group (31 patients, 70.45%) (P value
Full text
2,162 characters
· extracted from
oa-doi-fallback
· click to expand
Abstract
Background Endometriosis is a medical condition in women caused by the growth of active endometrial tissue outside the uterine cavity. It predominantly affects women of reproductive age and typically manifests as dysmenorrhea, dyspareunia, chronic pelvic pain, and infertility. It negatively impacts psychological well-being and health-related quality of life. Aim This study aims to compare the effect of the combination of letrozole and dydrogesterone versus the effect of dydrogesterone alone in pain-associated endometriosis Patients & Methods This randomized controlled study was conducted on 88 women with endometriosisassociated pain in the gynecologic outpatient clinic at Tanta University Hospitals, from October 2023 to September 2024. Patients were randomly divided into two equal groups, with 44 patients in each group. In the 1st group, Dydrogesterone (10 mg) twice daily and Letrozole (2.5 mg) once daily were administered from the 2nd day of menses continuously for 3 months. In the second group, Dydrogesterone (10 mg) was administered twice daily from the 2nd day of menses continuously for 3 months. The effectiveness of treatment was assessed by relief of symptoms. VAS, serum Estradiol, and CA 125 levels were measured before and after treatment. Results The mean age of patients was 30.11 ± 6.93 years in 1st group and 31.84 ± 7.98 years in 2nd group. Clinical effectiveness of treatment was significant in both groups but significantly better in the 1st group (40 patients, 90.90%) than the 2nd group (31 patients, 70.45%) (P value
Article Type
Original Study
Subject Area
Obstetrics and Gynecology
IRB Number
36264MS313/9/23
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 4.0 International License.
Recommended Citation
Elwakeel, Mohamed M.H.; Elsharawy, Mohamed A.T.; Dawod, Abdelghaffar S.; and ElKhouly, Dina G.
(2025)
"Combined effect of letrozole and dydrogesterone versus dydrogesterone alone for relieving pain in patients with endometriosis,"
Journal of Medicine in Scientific Research: Vol. 8:
Iss.
4, Article 11.
DOI: https://doi.org/10.59299/2537-0928.1471
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Ask this paper
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Outcome instruments
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK